FAE Faes Farma, S.A.

5.358USD4.885 EUR · BME-2.20%Mkt Cap: 1.67B USDP/E: 18.09

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Anima…

Key Statistics

Company
Market Cap1.67B USD
Enterprise Value2.01B USD
Revenue (TTM)807.83M USD
Gross Profit434.24M USD
Net Income (TTM)87.34M USD
Revenue/Share2.59 USD
Last Price5.358 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees2.7K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0134950F36
Valuation
P/E (Trailing)18.09
P/E (Forward)14.10
PEG0.91
EV/EBITDA14.74
EV/Revenue2.49
P/S2.06
P/B1.96
EPS (TTM)0.30 USD
EPS (Forward)0.38 USD
52W Range
4.73351% of range5.967
52W High5.967 USD
52W Low4.733 USD
Profitability
Gross Margin64.85%
Oper. Margin12.98%
EBITDA Margin16.89%
Profit Margin13.04%
ROE10.69%
ROA5.93%
ROIC8.16%
ROCE7.87%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF86.09M USD
CapEx (TTM)25.93M USD
FCF Margin—
FCF Yield—
Net Debt342.76M USD
Net Debt/EBITDA2.51
Net Debt/FCF—
Balance Sheet
Debt/Equity0.57
Current Ratio—
Quick Ratio—
Book Value/Sh2.73 USD
Cash/Share0.48 USD
Dividends
Fwd Div Rate0.14 USD
Trail. Div Rate0.10 USD
Div. Yield2.57%
5Y Avg Yield2.70%
Payout Ratio47.76%
Ex-Div DateJul 2, 2026
Pay Date—
Splits
Last Split27:26
Split DateApr 12, 2023
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.103 USD
Upside (mean)+13.9%
Target Range5.287 USD – 6.690 USD
5.287+13.9% to mean6.690
# Analysts5
Ownership
Shares Out.311.45M
Float218.33M
Insiders20.35%
Institutions15.71%
Technical
SMA 505.216 (+2.7%)
SMA 2005.147 (+4.1%)
Beta0.30
S&P 52W Chg12.00%
Avg Vol (30d)126.58K
Avg Vol (10d)153.89K
Technical Indicators
RSI (14)50.6
MACD0.0673
MACD Signal0.0680
MACD Hist.-0.0007
BB Upper5.616 USD
BB Middle5.355 USD
BB Lower5.095 USD
BB Width9.73%
ATR (14)0.1114 USD
Vol Ratio (20d)1.10x

About Faes Farma (BME: FAE)

›

Faes Farma (BME: FAE) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2,677 employees.

The shares were at 4.885 EUR on 19 November 2026, up 6.9% over 52 weeks. Its 52-week range is 4.315 EUR to 5.440 EUR: the price is 10.2% below the high and 13.2% above the low.

At a market capitalisation of 1.52B EUR, it trades at 18.1 times trailing earnings and 14.1 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 27% for FAE. It pays a dividend yielding 2.57% (it pays out 48% of its earnings), against a median of 1.90% among the dividend payers in that peer group.

Faes Farma reports return on equity of 10.7%, an operating margin of 13.0% and revenue up 17.4% year over year.

Its debt exceeds its cash by 312.50M EUR, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 5.564 EUR is 13.9% above the current price. The next earnings report is expected on 25 February 2027.